Differential behavioral outcomes of 3,4-methylenedioxymethamphetamine (MDMA-ecstasy) in anxiety-like responses in mice

Anxiolytic and anxiogenic-like behavioral outcomes have been reported for methylenedioxymethamphetamine (MDMA or ecstasy) in rodents. In the present experiment, we attempted to identify behavioral, hormonal and neurochemical outcomes of MDMA treatment to clarify its effects on anxiety-related responses in 2-month-old Balb/c male mice (25-35 g; N = 7-10 mice/group). The behavioral tests used were open field, elevated plus maze, hole board, and defensive behavior against predator odor. Moreover, we also determined striatal dopamine and dopamine turnover, and serum corticosterone levels. MDMA was injected ip at 0.2, 1.0, 5.0, 8.0, 10, or 20 mg/kg. MDMA at 10 mg/kg induced the following significant (P < 0.05) effects: a) a dose-dependent increase in the distance traveled and in the time spent moving in the open field; b) decreased exploratory activity in the hole board as measured by number of head dips and time spent in head dipping; c) increased number of open arm entries and increased time spent in open arm exploration in the elevated plus maze; d) increased time spent away from an aversive stimulus and decreased number of risk assessments in an aversive odor chamber; e) increased serum corticosterone levels, and f) increased striatal dopamine level and turnover. Taken together, these data suggest an anxiogenic-like effect of acute MDMA treatment, despite the fact that behavioral anxiety expression was impaired in some of the behavioral tests used as a consequence of the motor stimulating effects of MDMA.

Saved in:
Bibliographic Details
Main Authors: Ferraz-de-Paula,V., Stankevicius,D., Ribeiro,A., Pinheiro,M.L., Rodrigues-Costa,E.C., Florio,J.C., Lapachinske,S.F., Moreau,R.L.M., Palermo-Neto,J.
Format: Digital revista
Language:English
Published: Associação Brasileira de Divulgação Científica 2011
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2011000500008
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0100-879X2011000500008
record_format ojs
spelling oai:scielo:S0100-879X20110005000082011-11-11Differential behavioral outcomes of 3,4-methylenedioxymethamphetamine (MDMA-ecstasy) in anxiety-like responses in miceFerraz-de-Paula,V.Stankevicius,D.Ribeiro,A.Pinheiro,M.L.Rodrigues-Costa,E.C.Florio,J.C.Lapachinske,S.F.Moreau,R.L.M.Palermo-Neto,J. Corticosterone Open field Plus maze Hole board Predator odor test Ecstasy Anxiolytic and anxiogenic-like behavioral outcomes have been reported for methylenedioxymethamphetamine (MDMA or ecstasy) in rodents. In the present experiment, we attempted to identify behavioral, hormonal and neurochemical outcomes of MDMA treatment to clarify its effects on anxiety-related responses in 2-month-old Balb/c male mice (25-35 g; N = 7-10 mice/group). The behavioral tests used were open field, elevated plus maze, hole board, and defensive behavior against predator odor. Moreover, we also determined striatal dopamine and dopamine turnover, and serum corticosterone levels. MDMA was injected ip at 0.2, 1.0, 5.0, 8.0, 10, or 20 mg/kg. MDMA at 10 mg/kg induced the following significant (P < 0.05) effects: a) a dose-dependent increase in the distance traveled and in the time spent moving in the open field; b) decreased exploratory activity in the hole board as measured by number of head dips and time spent in head dipping; c) increased number of open arm entries and increased time spent in open arm exploration in the elevated plus maze; d) increased time spent away from an aversive stimulus and decreased number of risk assessments in an aversive odor chamber; e) increased serum corticosterone levels, and f) increased striatal dopamine level and turnover. Taken together, these data suggest an anxiogenic-like effect of acute MDMA treatment, despite the fact that behavioral anxiety expression was impaired in some of the behavioral tests used as a consequence of the motor stimulating effects of MDMA.info:eu-repo/semantics/openAccessAssociação Brasileira de Divulgação CientíficaBrazilian Journal of Medical and Biological Research v.44 n.5 20112011-05-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2011000500008en10.1590/S0100-879X2011007500046
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Ferraz-de-Paula,V.
Stankevicius,D.
Ribeiro,A.
Pinheiro,M.L.
Rodrigues-Costa,E.C.
Florio,J.C.
Lapachinske,S.F.
Moreau,R.L.M.
Palermo-Neto,J.
spellingShingle Ferraz-de-Paula,V.
Stankevicius,D.
Ribeiro,A.
Pinheiro,M.L.
Rodrigues-Costa,E.C.
Florio,J.C.
Lapachinske,S.F.
Moreau,R.L.M.
Palermo-Neto,J.
Differential behavioral outcomes of 3,4-methylenedioxymethamphetamine (MDMA-ecstasy) in anxiety-like responses in mice
author_facet Ferraz-de-Paula,V.
Stankevicius,D.
Ribeiro,A.
Pinheiro,M.L.
Rodrigues-Costa,E.C.
Florio,J.C.
Lapachinske,S.F.
Moreau,R.L.M.
Palermo-Neto,J.
author_sort Ferraz-de-Paula,V.
title Differential behavioral outcomes of 3,4-methylenedioxymethamphetamine (MDMA-ecstasy) in anxiety-like responses in mice
title_short Differential behavioral outcomes of 3,4-methylenedioxymethamphetamine (MDMA-ecstasy) in anxiety-like responses in mice
title_full Differential behavioral outcomes of 3,4-methylenedioxymethamphetamine (MDMA-ecstasy) in anxiety-like responses in mice
title_fullStr Differential behavioral outcomes of 3,4-methylenedioxymethamphetamine (MDMA-ecstasy) in anxiety-like responses in mice
title_full_unstemmed Differential behavioral outcomes of 3,4-methylenedioxymethamphetamine (MDMA-ecstasy) in anxiety-like responses in mice
title_sort differential behavioral outcomes of 3,4-methylenedioxymethamphetamine (mdma-ecstasy) in anxiety-like responses in mice
description Anxiolytic and anxiogenic-like behavioral outcomes have been reported for methylenedioxymethamphetamine (MDMA or ecstasy) in rodents. In the present experiment, we attempted to identify behavioral, hormonal and neurochemical outcomes of MDMA treatment to clarify its effects on anxiety-related responses in 2-month-old Balb/c male mice (25-35 g; N = 7-10 mice/group). The behavioral tests used were open field, elevated plus maze, hole board, and defensive behavior against predator odor. Moreover, we also determined striatal dopamine and dopamine turnover, and serum corticosterone levels. MDMA was injected ip at 0.2, 1.0, 5.0, 8.0, 10, or 20 mg/kg. MDMA at 10 mg/kg induced the following significant (P < 0.05) effects: a) a dose-dependent increase in the distance traveled and in the time spent moving in the open field; b) decreased exploratory activity in the hole board as measured by number of head dips and time spent in head dipping; c) increased number of open arm entries and increased time spent in open arm exploration in the elevated plus maze; d) increased time spent away from an aversive stimulus and decreased number of risk assessments in an aversive odor chamber; e) increased serum corticosterone levels, and f) increased striatal dopamine level and turnover. Taken together, these data suggest an anxiogenic-like effect of acute MDMA treatment, despite the fact that behavioral anxiety expression was impaired in some of the behavioral tests used as a consequence of the motor stimulating effects of MDMA.
publisher Associação Brasileira de Divulgação Científica
publishDate 2011
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2011000500008
work_keys_str_mv AT ferrazdepaulav differentialbehavioraloutcomesof34methylenedioxymethamphetaminemdmaecstasyinanxietylikeresponsesinmice
AT stankeviciusd differentialbehavioraloutcomesof34methylenedioxymethamphetaminemdmaecstasyinanxietylikeresponsesinmice
AT ribeiroa differentialbehavioraloutcomesof34methylenedioxymethamphetaminemdmaecstasyinanxietylikeresponsesinmice
AT pinheiroml differentialbehavioraloutcomesof34methylenedioxymethamphetaminemdmaecstasyinanxietylikeresponsesinmice
AT rodriguescostaec differentialbehavioraloutcomesof34methylenedioxymethamphetaminemdmaecstasyinanxietylikeresponsesinmice
AT floriojc differentialbehavioraloutcomesof34methylenedioxymethamphetaminemdmaecstasyinanxietylikeresponsesinmice
AT lapachinskesf differentialbehavioraloutcomesof34methylenedioxymethamphetaminemdmaecstasyinanxietylikeresponsesinmice
AT moreaurlm differentialbehavioraloutcomesof34methylenedioxymethamphetaminemdmaecstasyinanxietylikeresponsesinmice
AT palermonetoj differentialbehavioraloutcomesof34methylenedioxymethamphetaminemdmaecstasyinanxietylikeresponsesinmice
_version_ 1756391332947951616